WallStSmart

Bitfarms Ltd. (KEEL)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 13% more annual revenue ($258.90M vs $229.28M). ZEPP leads profitability with a -15.5% profit margin vs -124.1%. ZEPP earns a higher WallStSmart Score of 41/100 (D).

KEEL

Avoid

33

out of 100

Grade: F

Growth: 7.3Profit: 2.0Value: 5.0Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for KEEL.

ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KEEL1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
39.7%10/10

Revenue surging 39.7% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

KEEL4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.65B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-35.6%2/10

ROE of -35.6% — below average capital efficiency

Free Cash FlowQuality
$-97.76M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : KEEL

The strongest argument for KEEL centers on Revenue Growth. Revenue growth of 39.7% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : KEEL

The primary concerns for KEEL are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

KEEL carries more volatility with a beta of 3.72 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (41/100 vs 33/100) and 43.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bitfarms Ltd.

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Bitfarms Ltd. (KEEL) is a leading cryptocurrency mining company that specializes in the development and operation of blockchain infrastructure. With a commitment to sustainable energy solutions, Bitfarms utilizes renewable energy sources to power its mining operations, enhancing both efficiency and environmental responsibility. The company is strategically positioned to capitalize on the growing demand for cryptocurrency assets, leveraging cutting-edge technology and world-class expertise to drive operational excellence. As one of the largest Bitcoin miners in North America, Bitfarms continually seeks to expand its footprint while maintaining a focus on profitability and innovation in the rapidly evolving digital currency landscape.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?